A share price of Abbvie Inc [ABBV] is currently trading at $164.25, up 1.05%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The ABBV shares have lost -2.83% over the last week, with a monthly amount drifted -7.98%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Abbvie Inc [NYSE: ABBV] stock has seen the most recent analyst activity on January 29, 2024, when William Blair upgraded its rating to a Outperform. Previously, HSBC Securities downgraded its rating to Hold on December 18, 2023. On December 11, 2023, upgrade upgraded it’s rating to Buy. Deutsche Bank started tracking the stock assigning a Hold rating and suggested a price target of $150 on November 09, 2023. Barclays upgraded its rating to a Overweight and raised its price target to $170 on October 30, 2023. In a note dated September 29, 2023, Raymond James initiated an Outperform rating and provided a target price of $177 on this stock.
Abbvie Inc experienced fluctuations in its stock price throughout the past year between $130.96 and $182.89. Currently, Wall Street analysts expect the stock to reach $161.3 within the next 12 months. Abbvie Inc [NYSE: ABBV] shares were valued at $164.25 at the most recent close of the market. An investor can expect a potential drop of -1.8% based on the average ABBV price forecast.
Analyzing the ABBV fundamentals
Trailing Twelve Months sales for Abbvie Inc [NYSE:ABBV] were 54.32B which represents -5.42% decline. Gross Profit Margin for this corporation currently stands at 0.69% with Operating Profit Margin at 0.26%, Pretax Profit Margin comes in at 0.12%, and Net Profit Margin reading is 0.09%. To continue investigating profitability, this company’s Return on Assets is posted at 0.04, Equity is 0.4 and Total Capital is 0.15. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 5.73.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 163.41 points at the first support level, and at 162.56 for the second support level. However, for the 1st resistance point, the stock is sitting at 164.92, and for the 2nd resistance point, it is at 165.58.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Abbvie Inc [NYSE:ABBV] is 0.87. Also, the Quick Ratio is 0.76, while the Cash Ratio stands at 0.34. Considering the valuation of this stock, the price to sales ratio is 5.35, the price to book ratio is 28.00 and price to earnings (TTM) ratio is 60.38.
Transactions by insiders
Recent insider trading involved Donoghoe Nicholas, EVP, CHIEF BUS/STRAT OFFICER, that happened on Mar 20 ’24 when 21082.0 shares were sold. EVP, CHIEF COMMERCIAL OFFICER, Stewart Jeffrey Ryan completed a deal on Mar 18 ’24 to sell 58949.0 shares. Meanwhile, EVP, CHIEF HR OFFICER RICHMOND TIMOTHY J. sold 75680.0 shares on Mar 01 ’24.
